AI as a Medical Device

Written By

sophie vo Module
Sophie Vo

Associate
UK

I am a Senior Associate in the Intellectual Property Group in London with a particular focus on the life sciences and healthcare sectors.

Last month, the Medicines & Healthcare products Regulatory Agency (“MHRA“) published guidance on “Software and Artificial Intelligence (AI) as a Medical Device”. It didn’t necessarily provide for any new regulatory approach to AI in the therapeutic space, but it brought together some important material during this period of increasing interest in AI to effectively remind software providers of their compliance obligations in the life sciences and healthcare space.

Latest insights

More Insights
featured image

EU Revised Product Liability Directive 2024: Navigating the New Liability Framework for Non-EU Manufacturers

6 minutes Sep 04 2025

Read More
Curiosity line green background

Unlocking Section 444GA: When Courts Can Bless Share Transfers in a DoCA

Sep 02 2025

Read More
featured image

Transatlantic Tumult Triggering ESG Setbacks?

4 minutes Aug 22 2025

Read More